Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer.

Hanna GJ, Supplee JG, Kuang Y, Mahmood U, Lau CJ, Haddad RI, Jänne PA, Paweletz CP.

Ann Oncol. 2018 Jul 13. doi: 10.1093/annonc/mdy251. [Epub ahead of print]

PMID:
30010779
2.

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo).

Catalano OA, Umutlu L, Fuin N, Hibert ML, Scipioni M, Pedemonte S, Vangel M, Catana AM, Herrmann K, Nensa F, Groshar D, Mahmood U, Rosen BR, Catana C.

Eur J Nucl Med Mol Imaging. 2018 Jul 11. doi: 10.1007/s00259-018-4084-2. [Epub ahead of print]

PMID:
29998420
3.

Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.

Heidari P, Kunawudhi A, Martinez-Quintanilla J, Szretter A, Shah K, Mahmood U.

Theranostics. 2018 May 23;8(12):3380-3391. doi: 10.7150/thno.24017. eCollection 2018.

4.

C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Post-operative Residual Disease and Response to Chemoradiation Therapy.

Wang Y, Rapalino O, Heidari P, Loeffler J, Shih HA, Oh K, Mahmood U.

Int J Radiat Oncol Biol Phys. 2018 Jun 15. pii: S0360-3016(18)30964-7. doi: 10.1016/j.ijrobp.2018.06.011. [Epub ahead of print]

PMID:
29913253
5.

Specific 18F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models is Facilitated by Pre-Binding to Sex Hormone Binding Globulin.

Larimer BM, Dubois F, Bloch E, Nesti S, Placzek M, Zadra G, Hooker JM, Loda M, Mahmood U.

J Nucl Med. 2018 May 31. pii: jnumed.118.208785. doi: 10.2967/jnumed.118.208785. [Epub ahead of print]

PMID:
29853654
6.

The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along 10 Imaging Touch Points.

Li Q, Xiang F, Lin X, Grajo JR, Yang L, Xu Y, Duan Y, Vyas U, Harisinghani M, Mahmood U, Samir AE.

Urology. 2018 May 3. pii: S0090-4295(18)30395-9. doi: 10.1016/j.urology.2018.04.026. [Epub ahead of print] Review.

PMID:
29730256
7.

Clinicopathological Characteristics of Prostate Cancer in Patients Presenting to a Tertiary Care Private Sector Hospital.

Masood A, Iqbal N, Shohab D, Hasan A, Aimon S, Mahmood U, Akhter S.

J Coll Physicians Surg Pak. 2018 May;28(5):409-411. doi: 10.29271/jcpsp.2018.05.409.

PMID:
29690977
8.

Rapid switching kVp dual energy CT: Value of reconstructed dual energy CT images and organ dose assessment in multiphasic liver CT exams.

Mahmood U, Horvat N, Horvat JV, Ryan D, Gao Y, Carollo G, DeOcampo R, Do RK, Katz S, Gerst S, Schmidtlein CR, Dauer L, Erdi Y, Mannelli L.

Eur J Radiol. 2018 May;102:102-108. doi: 10.1016/j.ejrad.2018.02.022. Epub 2018 Feb 19.

PMID:
29685522
9.

In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors.

Begum S, Nizami SS, Mahmood U, Masood S, Iftikhar S, Saied S.

Comput Biol Chem. 2018 Jun;74:212-217. doi: 10.1016/j.compbiolchem.2018.04.003. Epub 2018 Apr 7.

PMID:
29653432
10.

Exradin W1 plastic scintillation detector for in vivo skin dosimetry in passive scattering proton therapy.

Alsanea F, Wootton L, Sahoo N, Kudchadker R, Mahmood U, Beddar S.

Phys Med. 2018 Mar;47:58-63. doi: 10.1016/j.ejmp.2018.02.014. Epub 2018 Feb 27.

PMID:
29609819
11.

Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease.

Catalano OA, Wu V, Mahmood U, Signore A, Vangel M, Soricelli A, Salvatore M, Gervais D, Rosen BR.

Am J Nucl Med Mol Imaging. 2018 Feb 5;8(1):62-69. eCollection 2018.

12.

Quantification of Iodine Concentration Using Single-Source Dual-Energy Computed Tomography in a Calf Liver.

Agostini A, Mahmood U, Erdi Y, Borgheresi A, Ragucci M, Sawan P, Ryan D, Laino ME, Corrias G, Mannelli L.

J Comput Assist Tomogr. 2018 Mar/Apr;42(2):222-229. doi: 10.1097/RCT.0000000000000685.

PMID:
29489589
13.

Patient-specific organ and effective dose estimates in pediatric oncology computed tomography.

Gao Y, Quinn B, Pandit-Taskar N, Behr G, Mahmood U, Long D, Xu XG, St Germain J, Dauer LT.

Phys Med. 2018 Jan;45:146-155. doi: 10.1016/j.ejmp.2017.12.013. Epub 2017 Dec 22.

14.

Transient Anosmia Induces Depressive-like and Anxiolytic-like Behavior and Reduces Amygdalar Corticotropin-Releasing Hormone in a ZnSO4-Induced Mouse Model.

Ahn S, Choi M, Kim H, Yang EJ, Mahmood U, Kang SI, Shin HW, Kim DW, Kim HS.

Chem Senses. 2018 Apr 23;43(4):213-221. doi: 10.1093/chemse/bjy008.

PMID:
29438489
15.

Radiotheranostics in Cancer Diagnosis and Management.

Jadvar H, Chen X, Cai W, Mahmood U.

Radiology. 2018 Feb;286(2):388-400. doi: 10.1148/radiol.2017170346. Review.

PMID:
29356634
16.

Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.

Mahmood U, Healy HG, Kark A, Cameron A, Wang Z, Abeysekera R, Hoy WE.

BMC Nephrol. 2017 Dec 28;18(1):372. doi: 10.1186/s12882-017-0781-5.

17.

Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study.

Blanchard P, Pugh TJ, Swanson DA, Mahmood U, Chen HC, Wang X, Graber WJ, Kudchadker RJ, Bruno T, Feeley T, Frank SJ.

Brachytherapy. 2018 Mar - Apr;17(2):265-276. doi: 10.1016/j.brachy.2017.11.007. Epub 2017 Dec 18.

PMID:
29269207
18.

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.

Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):374-382. doi: 10.1016/j.ijrobp.2017.09.050. Epub 2017 Oct 12.

19.

Sodium fluoride PET imaging as a quantitative pharmacodynamic biomarker for bone homeostasis during anti-DKK1 therapy for multiple myeloma.

Wang Y, Yee AJ, Sirard C, Landau S, Raje N, Mahmood U.

Blood Cancer J. 2017 Oct 6;7(10):e615. doi: 10.1038/bcj.2017.95. No abstract available.

20.

Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.

Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA.

BJU Int. 2018 Apr;121(4):540-548. doi: 10.1111/bju.14021. Epub 2017 Oct 17.

PMID:
28941030
21.

Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder.

Mahmood U, Ahn S, Yang EJ, Choi M, Kim H, Regan P, Cho K, Kim HS.

Pharmacol Res. 2018 Feb;128:110-121. doi: 10.1016/j.phrs.2017.08.006. Epub 2017 Aug 18.

22.

Radiological Tenckhoff catheter insertion for peritoneal dialysis: A cost-effective approach.

Lee J, Mott N, Mahmood U, Clouston J, Summers K, Nicholas P, Gois PHF, Ranganathan D.

J Med Imaging Radiat Oncol. 2018 Apr;62(2):174-178. doi: 10.1111/1754-9485.12643. Epub 2017 Aug 1.

PMID:
28762670
23.

Phage Display Selection, In Vitro Characterization, and Correlative PET Imaging of a Novel HER3 Peptide.

Larimer BM, Phelan N, Wehrenberg-Klee E, Mahmood U.

Mol Imaging Biol. 2018 Apr;20(2):300-308. doi: 10.1007/s11307-017-1106-6.

PMID:
28733706
24.
25.

Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy.

Koshy M, Malik R, Spiotto M, Mahmood U, Rusthoven CG, Sher DJ.

Lung Cancer. 2017 Jun;108:222-227. doi: 10.1016/j.lungcan.2017.04.006. Epub 2017 Apr 17.

PMID:
28625640
26.

Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinib.

Collier TL, Normandin MD, Stephenson NA, Livni E, Liang SH, Wooten DW, Esfahani SA, Stabin MG, Mahmood U, Chen J, Wang W, Maresca K, Waterhouse RN, El Fakhri G, Richardson P, Vasdev N.

Nat Commun. 2017 Jun 8;8:15761. doi: 10.1038/ncomms15761.

27.

Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.

Catalano OA, Daye D, Signore A, Iannace C, Vangel M, Luongo A, Catalano M, Filomena M, Mansi L, Soricelli A, Salvatore M, Fuin N, Catana C, Mahmood U, Rosen BR.

Int J Oncol. 2017 Jul;51(1):281-288. doi: 10.3892/ijo.2017.4012. Epub 2017 May 19.

PMID:
28535000
28.

A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68Ga-DOTATOC in healthy volunteers.

Esfahani SA, Salcedo S, Heidari P, Catalano OA, Pauplis R, Hesterman J, Kronauge JF, Mahmood U.

Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):53-62. eCollection 2017.

29.

Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.

Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala T, Blanchard P, Frank SJ.

Brachytherapy. 2017 Jul - Aug;16(4):761-769. doi: 10.1016/j.brachy.2017.04.004. Epub 2017 May 10.

30.

Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy.

Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE.

Prostate Cancer Prostatic Dis. 2017 Dec;20(4):389-394. doi: 10.1038/pcan.2017.24. Epub 2017 May 2.

PMID:
28462945
31.

Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.

Larimer BM, Wehrenberg-Klee E, Dubois F, Mehta A, Kalomeris T, Flaherty K, Boland G, Mahmood U.

Cancer Res. 2017 May 1;77(9):2318-2327. doi: 10.1158/0008-5472.CAN-16-3346.

32.

The declining utilization of brachytherapy for the treatment of prostate cancer: Can magnetic resonance imaging reverse the trend?

Mahmood U.

Brachytherapy. 2017 Jul - Aug;16(4):778-781. doi: 10.1016/j.brachy.2017.03.010. Epub 2017 Apr 29. Review.

PMID:
28460997
33.

A comparison of pediatric and adult CT organ dose estimation methods.

Gao Y, Quinn B, Mahmood U, Long D, Erdi Y, St Germain J, Pandit-Taskar N, Xu XG, Bolch WE, Dauer LT.

BMC Med Imaging. 2017 Apr 26;17(1):28. doi: 10.1186/s12880-017-0199-3.

34.

Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer.

Jackson MW, Amini A, Jones BL, Kavanagh B, Maroni P, Frank SJ, Mahmood U, Kudchadker RJ, Pugh TJ.

Brachytherapy. 2017 Jul - Aug;16(4):790-796. doi: 10.1016/j.brachy.2017.03.007. Epub 2017 Apr 23.

PMID:
28442277
35.

Alterations in protein phosphorylation in the amygdala of the 5XFamilial Alzheimer's disease animal model.

Yang EJ, Mahmood U, Kim H, Choi M, Choi Y, Lee JP, Chang MJ, Kim HS.

J Pharmacol Sci. 2017 Apr;133(4):261-267. doi: 10.1016/j.jphs.2017.03.005. Epub 2017 Mar 31.

36.

Thyroid neoplasms: incidental findings on extent of disease evaluation CT for other pediatric malignancies.

Hammond WJ, Heaton TE, Farber BA, Mahmood UA, Gluskin JS, Wolden SL, La Quaglia MP, Sklar CA, Price AP.

J Pediatr Surg. 2017 Jun;52(6):938-943. doi: 10.1016/j.jpedsurg.2017.03.015. Epub 2017 Mar 15.

37.

The assessment and characterization of the built-in internal photometer of primary diagnostic monitors.

Ruuge AE, Mahmood UA, Erdi YE.

J Appl Clin Med Phys. 2017 Mar;18(2):170-175. doi: 10.1002/acm2.12047. Epub 2017 Feb 2.

38.

Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging.

Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala T, Frank SJ.

Brachytherapy. 2017 Jul - Aug;16(4):728-733. doi: 10.1016/j.brachy.2017.02.001. Epub 2017 Mar 9.

39.

Molecular outcomes, clinical consequences, and genetic diagnosis of Oculocutaneous Albinism in Pakistani population.

Shahzad M, Yousaf S, Waryah YM, Gul H, Kausar T, Tariq N, Mahmood U, Ali M, Khan MA, Waryah AM, Shaikh RS, Riazuddin S, Ahmed ZM; University of Washington Center for Mendelian Genomics (UW CMG) Consortium.

Sci Rep. 2017 Mar 7;7:44185. doi: 10.1038/srep44185.

40.

PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.

Catalano OA, Horn GL, Signore A, Iannace C, Lepore M, Vangel M, Luongo A, Catalano M, Lehman C, Salvatore M, Soricelli A, Catana C, Mahmood U, Rosen BR.

Br J Cancer. 2017 Mar 28;116(7):893-902. doi: 10.1038/bjc.2017.26. Epub 2017 Feb 16.

41.

Insurance Status and Racial Disparities in Cancer-Specific Mortality in the United States: A Population-Based Analysis.

Pan HY, Walker GV, Grant SR, Allen PK, Jiang J, Guadagnolo BA, Smith BD, Koshy M, Rusthoven CG, Mahmood U.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):869-875. doi: 10.1158/1055-9965.EPI-16-0976. Epub 2017 Feb 9.

42.

Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.

Mahmood U, Isbel N, Mollee P, Mallett A, Govindarajulu S, Francis R.

Nephrology (Carlton). 2017 Feb;22 Suppl 1:15-17. doi: 10.1111/nep.12934. Review.

PMID:
28176474
43.

Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?

Chadha AS, Liu G, Chen HC, Das P, Minsky BD, Mahmood U, Delclos ME, Suh Y, Sawakuchi GO, Beddar S, Katz MH, Fleming JB, Javle MM, Varadhachary GR, Wolff RA, Crane CH, Wang X, Thames H, Krishnan S.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):323-332. doi: 10.1016/j.ijrobp.2016.10.046. Epub 2016 Nov 8.

PMID:
28068240
44.

18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.

Wang Y, Ayres KL, Goldman DA, Dickler MN, Bardia A, Mayer IA, Winer E, Fredrickson J, Arteaga CL, Baselga J, Manning HC, Mahmood U, Ulaner GA.

Clin Cancer Res. 2017 Jun 15;23(12):3053-3060. doi: 10.1158/1078-0432.CCR-16-2197. Epub 2016 Dec 23.

45.

Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR.

Catalano OA, Coutinho AM, Sahani DV, Vangel MG, Gee MS, Hahn PF, Witzel T, Soricelli A, Salvatore M, Catana C, Mahmood U, Rosen BR, Gervais D.

Abdom Radiol (NY). 2017 Apr;42(4):1141-1151. doi: 10.1007/s00261-016-0985-3.

PMID:
27891551
46.

Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model.

Ha S, Park H, Mahmood U, Ra JC, Suh YH, Chang KA.

Behav Brain Res. 2017 Jan 15;317:479-484. doi: 10.1016/j.bbr.2016.10.004. Epub 2016 Oct 4.

PMID:
27717813
47.

Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.

Qian ZR, Li T, Ter-Minassian M, Yang J, Chan JA, Brais LK, Masugi Y, Thiaglingam A, Brooks N, Nishihara R, Bonnemarie M, Masuda A, Inamura K, Kim SA, Mima K, Sukawa Y, Dou R, Lin X, Christiani DC, Schmidlin F, Fuchs CS, Mahmood U, Ogino S, Kulke MH.

Pancreas. 2016 Nov;45(10):1386-1393.

48.

Optical Imaging of Mesenchymal Epithelial Transition Factor (MET) for Enhanced Detection and Characterization of Primary and Metastatic Hepatic Tumors.

Esfahani SA, Heidari P, Kim SA, Ogino S, Mahmood U.

Theranostics. 2016 Sep 9;6(12):2028-2038. eCollection 2016.

49.

Prostate Cancer Imaging and Therapy: Potential Role of Nanoparticles.

Kilcoyne A, Harisinghani MG, Mahmood U.

J Nucl Med. 2016 Oct;57(Suppl 3):105S-110S. Review.

50.

Supplemental Content

Loading ...
Support Center